# MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms

> **NCT05285553** · NA · RECRUITING · sponsor: **CooperVision, Inc.** · enrollment: 900 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** MiSight 1 Day
- **DEVICE:** Proclear 1 day

## Key facts

- **NCT ID:** NCT05285553
- **Lead sponsor:** CooperVision, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-25
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05285553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05285553, "MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05285553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*